Overview
GLOW is Nova Biolabs' own formulated blend, combining GHK-Cu — a naturally occurring copper-binding tripeptide studied for its effects on skin and extracellular matrix research — with BPC-157 and TB-500, two of the most widely studied tissue-repair-associated research peptides. Where BPC-157 and TB-500 alone focus on regenerative and repair signalling, adding GHK-Cu extends the research profile into collagen and skin-remodelling territory, making GLOW a broader aesthetic and regenerative research reference than any single compound.
Nova Biolabs supplies GLOW as a pre-blended lyophilised 70mg vial from UK domestic stock.
Key Research Areas
Skin & Collagen Research
GHK-Cu is studied for its role in extracellular matrix remodelling and collagen-related signalling in skin research models.
Tissue Repair Research
BPC-157 and TB-500 are both independently studied for effects on tissue healing signalling across various in vitro and animal models.
Angiogenesis Studies
TB-500 has been studied for pro-angiogenic effects, including endothelial cell migration relevant to wound-healing research.
Combined Regenerative Signalling
The three-peptide combination is studied for potential complementary effects across skin, connective tissue, and repair-associated research models.
Product Specifications
| Format | Lyophilised powder blend |
| Composition | GHK-Cu + BPC-157 + TB-500, blended |
| Vial size | 70mg |
| Grade | Research Grade |
| Storage | Refrigerate at 2–8°C. Stable 24 months lyophilised. |
| Origin | UK domestic stock |
| Research use | In vitro / laboratory use only |
Reconstitution & Dosing Reference
GLOW is one of the few compounds where we publish a specific phased dosing reference, because it's a blend we formulated ourselves. This is a commonly cited research reference point — not medical dosing advice, and not a substitute for your own independent research.
| Phase | Weeks | Frequency |
|---|---|---|
| Activation | 1–4 | Daily |
| Remodeling | 5–8 | 5x per week |
| Maintenance | 9–12 | 2–3x per week |
Reconstituted with 2.5ml bacteriostatic water, a 2.8mg dose draws to 0.1ml — the 10-unit mark on a standard U-100 insulin syringe. Use our dosing calculator for a different reconstitution volume. Full guide: reconstitution-guide.html.
Frequently Asked Questions
Commonly Stacked With
Compounds researchers often study alongside this one, and why.
KLOW is GLOW’s four-compound sibling, adding KPV’s anti-inflammatory research — a common upgrade path for the same research goals.
GLOW is a pre-mixed version of this exact combination plus GHK-Cu — useful for comparing blended vs. individually-dosed research protocols.
GHK-Cu is frequently studied alongside BPC-157/TB-500 for comprehensive tissue-repair and regenerative signalling research.